Involvement of astrocytes in purine‐mediated reparative processes in the brain
Tóm tắt
Astrocytes are involved in multiple brain functions in physiological conditions, participating in neuronal development, synaptic activity and homeostatic control of the extracellular environment. They also actively participate in the processes triggered by brain injuries, aimed at limiting and repairing brain damages. Purines may play a significant role in the pathophysiology of numerous acute and chronic disorders of the central nervous system (CNS). Astrocytes are the main source of cerebral purines. They release either adenine‐based purines, e.g. adenosine and adenosine triphosphate, or guanine‐based purines, e.g. guanosine and guanosine triphosphate, in physiological conditions and release even more of these purines in pathological conditions. Astrocytes express several receptor subtypes of P1 and P2 types for adenine‐based purines. Receptors for guanine‐based purines are being characterised. Specific ecto‐enzymes such as nucleotidases, adenosine deaminase and, likely, purine nucleoside phosphorylase, metabolise both adenine‐ and guanine‐based purines after release from astrocytes. This regulates the effects of nucleotides and nucleosides by reducing their interaction with specific membrane binding sites. Adenine‐based nucleotides stimulate astrocyte proliferation by a P2‐mediated increase in intracellular [Ca2+] and isoprenylated proteins. Adenosine also, via A2 receptors, may stimulate astrocyte proliferation, but mostly, via A1 and/or A3 receptors, inhibits astrocyte proliferation, thus controlling the excessive reactive astrogliosis triggered by P2 receptors. The activation of A1 receptors also stimulates astrocytes to produce trophic factors, such as nerve growth factor, S100β protein and transforming growth factor β, which contribute to protect neurons against injuries. Guanosine stimulates the output of adenine‐based purines from astrocytes and in addition it directly triggers these cells to proliferate and to produce large amount of neuroprotective factors. These data indicate that adenine‐ and guanine‐based purines released in large amounts from injured or dying cells of CNS may act as signals to initiate brain repair mechanisms widely involving astrocytes.
Từ khóa
Tài liệu tham khảo
Abbracchio M.P., 1998, Purinergic signalling: pathophysiological roles, Jpn. J. Pharmacol., 78, 114
Abbracchio M.P., 1995, G protein‐dependent activation of phospholipase C by adenosine A3 receptors in rat brain, Mol. Pharmacol., 48, 1038
Anderson C., 2000, ATP‐activated glutamate release through non‐selective P2Z/P2X7 like channels in cultured mouse astrocytes, Drug Dev. Res., 50, 177
Ballerini P., 1995, Influence of Ca2+ channel modulators on [3H]purine release from rat cultured glial cells, Neurochem. Res., 20, 627, 10.1007/BF01705538
Ballerini P., 1997, Ionic modulation of P2X7 receptor‐mediated activity in rat brain astrocytes, Abstr. Soc. Neurosci., 23, 22
Ballerini P., 2000, P2X7 ATP receptor‐mediated modulation of astrocyte proliferation and coupling, Drug Dev. Res., 50, 240
Brunedge J.M., 1997, Role of adenosine as a modulator of synaptic activity in the central nervous system, Adv. Pharmacol., 39, 353, 10.1016/S1054-3589(08)60076-9
Bruno V., 1998, Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor‐β, J. Neurosci., 18, 9594, 10.1523/JNEUROSCI.18-23-09594.1998
Caciagli F., 1999, The hypoxanthine analogue AIT‐082 mimics the activity of guanosine in affecting extracellular adenosine breakdown and glutamate reuptake in rat cultured astrocytes, Abstr. Soc. Neurosci., 25, 1195
Caciagli F., 1996, mGluRs and purinoceptors cooperate in regulating excitatory amino acid and purine release, Neuropharmacology, 35, 24, 10.1016/0028-3908(96)84668-5
Chen Y., 1993, Adenosine and guanosine increase free cytosolic calcium concentration in mouse brain astrocytes through different receptors, Abstr. Soc. Neurosci., 19, 687
Ciccarelli R., 1995, Non‐uniform effects mediated by P2Y receptors on the proliferation of cultured astrocytes, Res. Commun. Mol. Pathol. Pharmacol., 87, 47
Ciccarelli R., 1995, Isopentenyladenosine involvement in P2‐mediated proliferation of cultured rat astrocytes, Pharmacol. Res., 31, 177, 10.1016/1043-6618(95)86968-9
Ciccarelli R., 1996, Modulation by metabotropic glutamate receptors of GTP effect on rat astrocyte proliferation, Drug Dev. Res., 37, 168
Ciccarelli R., 1997, Potential neuroprotective effects of guanine‐based purines released from rat cultured astrocytes, Proceedings of the II International EPHAR Meeting – ‘Drug targets in heart and brain ischemia’ Florence, 39
Ciccarelli R., 1998, Guanine‐based purines are released from rat astrocytes. Effects of these compounds on astrocyte function, Drug Dev. Res., 43, 52
Ciccarelli R., 1999, Guanosine and related drugs stimulate the production of trophic factors from rat cultured astrocytes by involving mitogen‐activated protein kinase pathway, Abstr. Soc. Neurosci., 29, 1013
Ciccarelli R., 2000, A1 adenosine receptors and mGlu3 metabotropic receptors modulate purine release and neurotrophin production from rat cultured astrocytes by different molecular pathways, Drug Dev. Res., 50, 173
Cory J.G., 1997, Textbook of Biochemistry with Clinical Correlations, 489
Crocker C.E., 1997, Effect of AIT‐082 on neurotrophin levels following spinal cord hemisection, Abstr. Soc. Neurosci., 23, 1149
deSouza L.R., 1991, The involvement of ecto‐ATPase activity in the phosphorylation of intracellular proteins by the addition of extracellular [32P]ATP in PC12 cells, Neurochem. Int., 19, 581, 10.1016/0197-0186(91)90079-S
Di Iorio P., 1999, The hypoxanthine derivative AIT‐082 is protective against NMDA‐ or kainic acid‐induced rat hippocampal neurotoxicity in vivo, Abstr. Soc. Neurosci., 25, 756
Eelles J.T., 1983, Identification, development and regional distribution of ribonucleotide reductase in adult rat brain, J. Neurochem., 40, 1008, 10.1111/j.1471-4159.1983.tb08085.x
Fairbanks L.D., 1990, Mechanisms of deoxyguanosine lymphotoxicity. Human thymocytes, but not peripheral blood lymphocytes accumulate deoxy‐GTP in conditions simulating purine nucleoside phosphorylase deficiency, J. Immunol., 144, 485, 10.4049/jimmunol.144.2.485
Glasky A.J., 1995, A novel purine derivative AIT‐082 increases synthesis of NGF, FGF‐2 and NT‐3 mRNA in astrocytes, Abstr. Soc. Neurosci., 21, 295
Glasky A.J., 1996, Elevation of brain mRNA for neurotrophin by oral AIT‐082 in mice, Abstr. Soc. Neurosci., 22, 751
Hansson E., 2000, Astroglia and glutamate in physiology and pathology: aspects on glutamate transport, glutamate‐induced cell swelling and gap‐junction communication, Neurochem. Int., 37, 319, 10.1016/S0197-0186(00)00033-4
Hindley S., 1994, Nitric oxide and carbon monoxide enhance neurite outgrowth from PC12 cells by activating soluble guanylate cyclase. IUPHAR Satellite Meeting: Nitric Oxide in the Nervous System, Neuropharmacology, 11, 140
Hoffaker T., 1984, Adenosine inhibits cell division and promotes neurite extension in PC12 cells, J. Cell Physiol., 120, 188, 10.1002/jcp.1041200212
Jung P., 1998, Noise‐induced spiral waves in astrocyte syncytia show evidence of self‐organized criticality, J. Neurophysiol., 79, 1098, 10.1152/jn.1998.79.2.1098
Juurlink B.H.J., 1998, The hypoxanthine derivative AIT‐082 promotes neurite formation and regeneration in cultured hippocampal neurons, Abstr. Soc. Neurosci., 24, 1941
Kittner B., 1999, Clinical trials of propentofylline in vascular dementia. European/Canadian Propentofylline Study group, Alzheimer Dis. Ass. Disord., 13, S166
Lowe J.K., 1977, Deoxyadenosine metabolism and toxicity in cultured L5178Y cells, Cancer Res., 37, 3013
Marchetti B., 1997, Cross talk signals in the CNS: role for neurotrophic and hormonal factors, adhesion molecules and intercellular signaling agents in luteinizing hormone‐releasing hormone (LHRH)‐astroglial interactive network, Front. Biosci., 5, d88, 10.2741/A177
Markert M.L., 1991, Purine nucleoside phosphorylase deficiency, Immunodefic. Rev., 3, 45
Mielke R., 1998, Propentofylline in the treatment of vascular dementia and Alzheimer‐type dementia: overview of phase I and phase II clinical trials, Alzheimer Dis. Ass. Dis., 12, S29
Nabeshuma T., 1994, Oral administration of NGF synthesis stimulators recovers reduced brain NGF content in aged rats and cognitive dysfunction in basal‐forebrain‐lesioned rats, Gerontology, 40, 46, 10.1159/000213627
Olanow C.W., 1993, A radical hypothesis for neurodegeneration, Trends Neurosci., 16, 11, 10.1016/0166-2236(93)90070-3
Picher M., 2000, Metabolism of extracellular nucleotides in human airways by a multi‐enzyme system, Drug Dev. Res., 50, 255
Ramirez J.J., 1998, The effects of AIT‐082 on septodentate sprouting after unilateral enthorinal cortex lesions in rats, Drug Dev. Res., 45, 58
Rathbone M.P., 1993, Hippocampal neurons in vitro respond to extracellular guanosine and GTP with neurite outgrowth and branching, Soc. Neurosci. Abstr., 19, 38
Rathbone M.P., 1997, Effects of guanosine and 2‐chloroadenosine on C6 glioma cell growth, Abstr. Soc. Neurosci., 23, 71
Rathbone M.P., 1998, The trophic effect of purines and purinergic signaling in pathologic reactions of astrocytes, Alzheimer Dis. Ass. Dis., 12, S36, 10.1097/00002093-199803001-00006
Rathbone M.P., 2000, Purine‐induced apoptosis of astrocytes is mediated by adenosine, Drug Dev. Res., 50, 33
Rudolphi K.A., 1992, Adenosine and brain ischemia, Cerebrov. Brain Metab. Rev., 4, 346
Rudolphi K.A., 1991, Adenosine and Adenosine Nucleotides as Regulators of Cellular Function, 423
Schiffer D., 1996, Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis, J. Neurol. Sci., 139, 27, 10.1016/0022-510X(96)00073-1
Schultz V., 1976, Purine nucleoside cycle: evidence for the occurrence of the cycle in brain, J. Biol. Chem., 251, 485, 10.1016/S0021-9258(17)33905-4
Schultz V., 1978, The purine nucleotide cycle: studies of ammonia production and interconversions of adenine and hypoxanthine nucleotides and nucleosides by rat brain, J. Biol. Chem., 253, 1938, 10.1016/S0021-9258(19)62338-0
Suk D., 1970, Toxicological and antiproliferative effects of N6‐ (Δ2‐Isopentenyl)adenosine, a natural component of mammalian tRNA, Cancer Res., 30, 1429
Traversa U., 2000, Evidence for a guanosine receptor functionally linked to mitogen‐activated protein kinase pathway, Drug Dev. Res., 50, 32